Mammalian Transient Protein Expression Market by Product, Application, End User & Region | Forecast 2023 to 2033
In the Past Few Years, the Mammalian Transient Protein Market has Grown Exponentially Due to Advancements in Biotechnological Processes. Explore More Current Market Trends with FMI!
Mammalian Transient Protein Expression Market Outlook (2023 to 2033)
As per the latest market research conducted by FMI, the global mammalian transient protein expression market is expected to record a CAGR of 8.5% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 697.2 million. By 2033, the valuation is anticipated to reach US$ 1581.6 million.
Mammalian Transient Protein (MTP) is a type of protein found in mammalian cells that is only present for a short period of time. It is involved in several processes necessary for the cell to function and survive, including DNA replication, cell division, and protein synthesis. They also play an important role in apoptosis, the process through which cells die when they are no longer needed.
Important Elements that Might Fuel Market Expansion Include:
The mammalian transient protein expression market has seen significant growth in recent years. This growth is due to increased research and development activities in the industry, as well as improvements in technology and techniques that are allowing for more accurate and efficient protein production, which on the other hand, is also driving the growth of the mammalian cells for protein expression market.
Another factor contributing to the mammalian transient protein expression market growth is the rising demand for therapeutic proteins and other drugs.
The introduction of new delivery systems, such as nanotechnology and drug-delivery vehicles, is facilitating the use of mammalian cells for protein expression as therapeutic agents and is likely to drive the growth of mammalian cells for protein expression market in the coming future.
Major industries, such as the pharmaceutical and biomedical sectors, have been the driving force behind the growth of the mammalian transient protein market, as they require significant volumes of high-quality transient proteins for their research and development.
These proteins are also frequently utilized in clinical tests and diagnoses due to their high degree of accuracy. The need for more effective production techniques has arisen as a result of increasing demand, which has led to a growth in proteins employed in technological advancement.
Mammalian cell expression is used for structural, therapeutic, and functional studies. Hence it is predicted to drive the growth of the mammalian cell expression market in the coming years.
Attributes
Value
Mammalian Transient Protein Expression Value (2022)
US$ 641.0 million
Mammalian Transient Protein Expression Market Expected Value (2023)
US$ 697.2 million
Mammalian Transient Protein Expression Market Forecast Value (2033)
1581.6 million
Mammalian Transient Protein Expression Market Expected CAGR (2023 to 2033)
8.5%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Comparison of the Historical CAGR (2018 to 2022) with the Anticipated CAGR (2023 to 2033)
The sale of mammalian transient protein expression recorded a CAGR of 9.6% from 2018 to 2022, owing to the increased usage of antibodies in the research studies for technological advancements.
Concerns regarding the applicability of current protein expression techniques are raised by the increased need for recombinant vaccine antigens and immunotherapeutic drugs. A small amount of expressed materials can be used in the manufacturing of vaccines, which falls into a fairly complex category with many different target antigens that have unique structural traits.
The contamination- and toxic-elements-free strategy is also driving up demand for mammalian transient protein expression. The risk of contamination is minimized when using the mammalian transient protein expression method since there are fewer potential foreign material contaminants.
Besides that, the absence of any nuclease activities ensures that linear DNA templates are constant during protein synthesis and supply all the purified components necessary to generate a recombinant protein in vitro. With these capabilities, protein expression in applied biologics and genomics is anticipated to reach new heights.
So, these factors present a tremendous growth potential for the market's investors to drive market expansion at an expected CAGR of 8.5% from 2023 to 2033 globally.
Comparative View of the Mammalian Transient Protein Expression Market
Mammalian Transient Protein Expression Market:
Attributes
Mammalian Transient Protein Expression Market
Anticipated CAGR (2023 to 2033)
8.5%
Market Value (2023)
US$ 697.2 million
Growth Factor
Rising demand for therapeutic proteins and other drugs.
Future Opportunities
The introduction of new delivery systems, such as nanotechnology and drug-delivery vehicles.
Restraint
High cost, risk of contamination, and ethical issues.
Prothrombin Complex Concentrates Market:
Attributes
Prothrombin Complex Concentrates Market
Anticipated CAGR (2023 to 2033)
4.1%
Market Value (2023)
US$ 1.2 billion
Growth Factor
Regulatory bodies are giving more product approvals.
Future Opportunities
Hemophilia B is becoming more common.
Restraint
PCC-related thrombotic complication.
Anticoagulant Reversal Drugs Market:
Attributes
Anticoagulant Reversal Drugs Market
Anticipated CAGR (2023 to 2033)
14.9%
Market Value (2023)
US$ 4571.40 million
Growth Factor
Acquisitions and mergers are getting more attention.
Future Opportunities
More and more people with blood problems need anticoagulants in case of uncontrolled bleeding.
Find your sweet spots for generating winning opportunities in this market.
Key Aspects of the Mammalian Transient Protein Expression Market
The mammalian transient protein expression market is a key component of the bigger mammalian cells for protein expression market. Companies are utilizing this technology to produce and express functional proteins, polypeptides, and other molecules in mammalian cells for various commercial and research applications.
The process of transient mammalian expression involves introducing a gene into cells, which is expected to quickly and efficiently produce the protein. This process allows for quick production and characterization of the expressed genes with a short turnaround time. Thus these factors are expected to fuel the growth of mammalian cells for protein expression market.
The global demand for biological therapeutics has been driven by the rising prevalence of contagious diseases like polio, COVID-19, and chicken pox, as well as the rise in the diagnostic population for variant diseases. This has created an opportunity for the growth of the global market for mammalian transient protein expression. According to estimates, the COVID-19 vaccination is given to over 75% of the world's population in one dose and to over 65% of the population in two doses.
Since protein expression systems are open systems, they permit the incorporation of a wide range of organic and inorganic materials into the reaction medium, including reducing/oxidizing agents, regulatory proteins, tagged amino acids, and detergents, making them suitable for a variety of proteomics studies.
Recombinant proteins, in contrast to chemical compounds, are enormous, complex molecules with intricate and varied mechanisms. Since the chemical synthesis of proteins is very challenging due to their size and complexity, recombinant proteins are created biologically using the machinery for protein synthesis.
Each manufacturing system has benefits and drawbacks in terms of production time, operational costs, protein supply, potential pathogenic microbial contamination, posttranslational modifications, and regulatory approval. These elements should be taken into consideration in order to provide market participants with a very profitable market opportunity.
The fact that the resulting recombinant protein is more likely to have post-translational modifications (PTMs) that are similar to those seen in normal human proteins is one of the most significant advantages of using human cell lines for protein expression.
Besides that, new mammalian cell lines have the ability to produce post-translational modifications that are similar to those produced by human cells as well as non-human PTMs such as galactose-1,3-galactose and N-glycolylneuraminic acid, all of which have the potential to be immunogenic.
How has the Market Progressed?
Particulars
Details
H1, 2021
8.96%
H1, 2022 Projected
8.95%
H1, 2022 Outlook
8.26%
BPS Change - H1, 2022 (O) - H1, 2022 (P)
(-) 70 ↓
BPS Change - H1, 2022 (O) - H1, 2021
(-) 71 ↓
The comparative analysis and the review analysis of market dynamics and market growth rate of the global mammalian transient protein expression market, as studied by Future Market Insights, showed a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 70 BPS, and, a negative BPS growth is expected in H1-2022 over H1- 2021 duration with 71 Basis Point Share (BPS).
The market observes a decline in the BPS values owed to the high risk of contamination, the high-cost factor associated with mammalian transient protein expression, and the ethical issues pertaining to the use of mammalian cells in the research and development of therapeutics and drugs.
The market is anticipated to increase positively throughout the course of the forecast period, however, as a result of the current expansion in the bioprocessing sector, which is supported by significant government investment as well as partnerships and contracts between CROs and CMOs.
According to the macro and industry dynamics, the market is subject to legal requirements, moral considerations, and environmental sustainability.
The values given in the below table has been taken from the FMI website.
As per the table shared, the value show 9.6%.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
What are the Primary Business Opportunities for Producers of Mammalian Transient Protein Expression Kits?
The market for mammalian transient protein expression is anticipated to develop in terms of revenue as a result of the rising frequency of chronic diseases and the expansion of manufacturing facilities. An economic boost to the expansion of the mammalian transient protein expression industry has resulted from the rising prevalence of chronic diseases such as hepatitis, AIDS, cancers, and infectious diseases, as well as the rise in the diagnostic population for mutant disorders.
Typically, different immuno- and bio-therapeutic compounds are produced using mammalian cell lines. The focus of top producers is on improving the productivity, adaptability, and throughput capacities of protein production employing mammalian cell lines while also redefining control productivity.
The competition within the global mammalian transient protein expression market is likely to be fueled by rising service consolidation activities such as partnerships, an increase in research and development activities, new service launches, partnering, and acquisitions & mergers among global and regional companies.
For instance, in September 2021, Promega Corporation introduced the OncoMate MSI Dx Analysis System in vitro diagnostic (IVD) in the United States, giving oncologists and pathologists a new technique to check for Lynch syndrome in people with colorectal cancer. OncoMate MSI was given FDA approval in August 2021 to be used as an IVD medical device to assess the state of microsatellite instability (MSI) in colorectal cancer tumors.
Together, these elements are expected to support the expansion of the mammalian transient protein expression market and offer profitable prospects to significant market participants throughout the course of the projection period.
What Factors are Anticipated to Limit the Growth of the Mammalian Transient Protein Expression Market?
The growth of the mammalian transient protein expression market is likely to be affected by certain factors such as high cost, risk of contamination, and ethical issues. The high cost of the production of mammalian cell-derived therapeutic and industrial proteins and the associated risk of pathogenic contaminations and chemical toxicity in the animal cell culture are likely to increase significant biosafety concerns.
The ethical consideration associated with the use of animal cell culture also decelerates the acceptance of mammalian-derived protein products. The global market for mammalian transient protein expression is expected to grow slowly as a result of these reasons combined.
Using human cell lines may also carry the risk of human-specific virus contamination. However, this risk can be minimized by employing viral inactivation or clearing procedures.
Likewise, despite the fact that human cell lines are currently widely used for biopharmaceutical research, vaccine production, and the creation of licensed protein therapies, clinical experience with human cell lines is limited as a result of their recent introduction to protein production (compared with other types of cell lines).
Human cell lines may be improved with thorough studies for routine commercial production of a greater variety of bio-therapeutic proteins. Together, these obstacles prevent the market from expanding during the forecast period.
Countries
CAGR (2023 to 2033)
United States
8.4%
China
9.0%
Canada
9.0%
Country-wise Insights
What Aspects are Anticipated to Make the United States the Significant Market for Mammalian Transient Protein Expression in the Coming Future?
The mammalian transient protein expression market in the United States is likely to record a CAGR of 8.4% over the forecast period. Due to the rising rate of cancer and other chronic diseases in the country, the United States is likely to be a dominating market for mammalian transient protein expression.
According to the CDC, colorectal cancer is the fourth most prevalent disease in the country. As funding and government assistance for performing research in numerous fields increase, the mammalian transient protein expression market is likely to gain attention.
What Factors are Expected to make China an Emerging Market for Mammalian Transient Protein Expression?
The mammalian transient protein expression market in China is likely to record a CAGR of 9.0% over the forecast period. Contract research activity is based in China. China's expanding medication discovery and research activities are the cause of the rising use of recombinant cell culture media supplements. Also, there are numerous domestic pharmaceutical companies in China, which on the other hand, is projected to drive market growth.
Category-wise Insights
Which Product of Mammalian Transient Protein Expression is Expected to Drive the Market Growth?
The reagents and consumables segment recorded a CAGR of 10.6% from 2018 to 2022 and is expected to record a CAGR of 9.6% from 2023 to 2033. The development of affordable and effective transfection reagents, including polyethyleneimine, enables the large-scale transient transfection of constructs, making it possible to use mammalian cell cultures for biologics and protein synthesis in a more effective way.
Which End User is Likely to Benefit the Mammalian Transient Protein Expression Market?
The biopharmaceutical companies segment recorded a CAGR of 9.8% from 2018 to 2022 and is expected to record a CAGR of 9.1% from 2023 to 2033. The demand for various target therapy and the expansion of biopharmaceutical companies are both on the rise.
Also, greater results in terms of time management and process flow maintenance have been produced via optimized equipment designs and increasing use of single-use technologies.
Competitive Landscape
Product development and market expansion are significant aspects in the mammalian transient protein expression market. As a result, market participants are likely to have a better overall revenue share in the global mammalian transient protein expression market. This is expected to help market players to improve their product portfolios and market penetration rate.
Important Developments in the Market:
In April 2022, Thermo Fisher Scientific released the Gibco CTS TrueCut Cas9 Protein, which was made by GMP standards.
Merck KgaA announced its expansion in October 2020, which inaugurated a new membrane production plant in Darmstadt, Germany. The goal was to increase the production of Millipore Express® membranes.
Similarly, recent developments related to companies manufacturing mammalian transient protein expression products have been tracked by the team at Future Market Insights, which are available in the full report.
Report Scope as per Mammalian Transient Protein Expression Industry Analysis
Attribute
Details
Forecast Period
2023 to 2033
Historical Data Available for
2018 to 2022
Market Analysis
US$ million for Value
Key Regions Covered
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered
United States, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, South Africa, GCC Countries, and Türkiye
Key Market Segments Covered in Mammalian Transient Protein Expression Industry Research
By Product:
Instruments
Expression Vector
Reagents & Consumables
Cell Lines
Chinese Hamster Ovary Cells (CHO)
Human embryonic kidney 293 (HEK 293) cells
Others
By Application:
Bio-production
Antibody Production
Therapeutic protein production
Functional Cell-Based Assays
Academic Research
Others
By End User:
Contract Research Organization
Biopharmaceutical Companies
Academic & Research Institutes
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
The Middle East and Africa (MEA)
Frequently Asked Questions
The United States generated higher demand with a CAGR of 8.5% in 2023.
North America market to grow at a maximum revenue through 2033.
Reagents and consumable segment contributes a CAGR of 9.6% of total production.
Pharmaceuticals hold a maximum CAGR of 9.1% of the global market share.
From 2018 to 2022, the global market exhibited a 9.6% CAGR.
Table of Content
1. Executive Summary | Mammalian Transient Protein Expression Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Instruments
5.3.2. Expression Vector
5.3.3. Reagents & Consumables
5.3.4. Cell Lines
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Bio-production
6.3.1.1. Antibody production
6.3.1.2. Therapeutic protein production
6.3.2. Functional Cell-Based Assays
6.3.3. Others
6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End-User , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User , 2023 to 2033
7.3.1. Contract Research Organization
7.3.2. Biopharmaceutical Companies
7.3.3. Academic & Research Institutes
7.4. Y-o-Y Growth Trend Analysis By End-User , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End-User , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. South Asia
8.3.5. East Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. The USA
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Application
9.2.4. By End-User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Application
9.3.4. By End-User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Application
10.2.4. By End-User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Application
10.3.4. By End-User
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product
11.2.3. By Application
11.2.4. By End-User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Application
11.3.4. By End-User
11.4. Key Takeaways
12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Malaysia
12.2.1.3. Singapore
12.2.1.4. Thailand
12.2.1.5. Rest of South Asia
12.2.2. By Product
12.2.3. By Application
12.2.4. By End-User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Application
12.3.4. By End-User
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product
13.2.3. By Application
13.2.4. By End-User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Application
13.3.4. By End-User
13.4. Key Takeaways
14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product
14.2.3. By Application
14.2.4. By End-User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Application
14.3.4. By End-User
14.4. Key Takeaways
15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product
15.2.3. By Application
15.2.4. By End-User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Application
15.3.4. By End-User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product
16.1.2.2. By Application
16.1.2.3. By End-User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product
16.2.2.2. By Application
16.2.2.3. By End-User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product
16.3.2.2. By Application
16.3.2.3. By End-User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product
16.4.2.2. By Application
16.4.2.3. By End-User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product
16.5.2.2. By Application
16.5.2.3. By End-User
16.6. United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product
16.6.2.2. By Application
16.6.2.3. By End-User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product
16.7.2.2. By Application
16.7.2.3. By End-User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product
16.8.2.2. By Application
16.8.2.3. By End-User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product
16.9.2.2. By Application
16.9.2.3. By End-User
16.10. India
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product
16.10.2.2. By Application
16.10.2.3. By End-User
16.11. Malaysia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product
16.11.2.2. By Application
16.11.2.3. By End-User
16.12. Singapore
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product
16.12.2.2. By Application
16.12.2.3. By End-User
16.13. Thailand
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product
16.13.2.2. By Application
16.13.2.3. By End-User
16.14. China
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product
16.14.2.2. By Application
16.14.2.3. By End-User
16.15. Japan
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product
16.15.2.2. By Application
16.15.2.3. By End-User
16.16. South Korea
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product
16.16.2.2. By Application
16.16.2.3. By End-User
16.17. Australia
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product
16.17.2.2. By Application
16.17.2.3. By End-User
16.18. New Zealand
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product
16.18.2.2. By Application
16.18.2.3. By End-User
16.19. GCC Countries
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product
16.19.2.2. By Application
16.19.2.3. By End-User
16.20. South Africa
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product
16.20.2.2. By Application
16.20.2.3. By End-User
16.21. Israel
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product
16.21.2.2. By Application
16.21.2.3. By End-User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Application
17.3.4. By End-User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Thermofisher Scientific
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Merck KGaA
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Promega Corporation
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Lonza
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Agilent Technologies, Inc.
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Bio-Rad
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Qiagen
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Takara Bio
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. HiMedia Laboratories.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Mirus
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Sino Biological, Inc.
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
19. Assumptions & Acronyms Used20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Product, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 4: Global Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by Product, 2018 to 2033
Table 7: North America Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 8: North America Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 10: Latin America Market Value (US$ Million) Forecast by Product, 2018 to 2033
Table 11: Latin America Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 12: Latin America Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: Europe Market Value (US$ Million) Forecast by Product, 2018 to 2033
Table 15: Europe Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 16: Europe Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Table 17: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 18: South Asia Market Value (US$ Million) Forecast by Product, 2018 to 2033
Table 19: South Asia Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 20: South Asia Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Table 21: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 22: East Asia Market Value (US$ Million) Forecast by Product, 2018 to 2033
Table 23: East Asia Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 24: East Asia Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Table 25: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 26: Oceania Market Value (US$ Million) Forecast by Product, 2018 to 2033
Table 27: Oceania Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 28: Oceania Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Table 29: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 30: MEA Market Value (US$ Million) Forecast by Product, 2018 to 2033
Table 31: MEA Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 32: MEA Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Product, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Application, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by End-User , 2023 to 2033
Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 8: Global Market Value (US$ Million) Analysis by Product, 2018 to 2033
Figure 9: Global Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 10: Global Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 11: Global Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 14: Global Market Value (US$ Million) Analysis by End-User , 2018 to 2033
Figure 15: Global Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033
Figure 16: Global Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033
Figure 17: Global Market Attractiveness by Product, 2023 to 2033
Figure 18: Global Market Attractiveness by Application, 2023 to 2033
Figure 19: Global Market Attractiveness by End-User , 2023 to 2033
Figure 20: Global Market Attractiveness by Region, 2023 to 2033
Figure 21: North America Market Value (US$ Million) by Product, 2023 to 2033
Figure 22: North America Market Value (US$ Million) by Application, 2023 to 2033
Figure 23: North America Market Value (US$ Million) by End-User , 2023 to 2033
Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 28: North America Market Value (US$ Million) Analysis by Product, 2018 to 2033
Figure 29: North America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 30: North America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 31: North America Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 34: North America Market Value (US$ Million) Analysis by End-User , 2018 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033
Figure 37: North America Market Attractiveness by Product, 2023 to 2033
Figure 38: North America Market Attractiveness by Application, 2023 to 2033
Figure 39: North America Market Attractiveness by End-User , 2023 to 2033
Figure 40: North America Market Attractiveness by Country, 2023 to 2033
Figure 41: Latin America Market Value (US$ Million) by Product, 2023 to 2033
Figure 42: Latin America Market Value (US$ Million) by Application, 2023 to 2033
Figure 43: Latin America Market Value (US$ Million) by End-User , 2023 to 2033
Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 48: Latin America Market Value (US$ Million) Analysis by Product, 2018 to 2033
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 51: Latin America Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 54: Latin America Market Value (US$ Million) Analysis by End-User , 2018 to 2033
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033
Figure 57: Latin America Market Attractiveness by Product, 2023 to 2033
Figure 58: Latin America Market Attractiveness by Application, 2023 to 2033
Figure 59: Latin America Market Attractiveness by End-User , 2023 to 2033
Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 61: Europe Market Value (US$ Million) by Product, 2023 to 2033
Figure 62: Europe Market Value (US$ Million) by Application, 2023 to 2033
Figure 63: Europe Market Value (US$ Million) by End-User , 2023 to 2033
Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 68: Europe Market Value (US$ Million) Analysis by Product, 2018 to 2033
Figure 69: Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 70: Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 71: Europe Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 72: Europe Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 73: Europe Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 74: Europe Market Value (US$ Million) Analysis by End-User , 2018 to 2033
Figure 75: Europe Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033
Figure 76: Europe Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033
Figure 77: Europe Market Attractiveness by Product, 2023 to 2033
Figure 78: Europe Market Attractiveness by Application, 2023 to 2033
Figure 79: Europe Market Attractiveness by End-User , 2023 to 2033
Figure 80: Europe Market Attractiveness by Country, 2023 to 2033
Figure 81: South Asia Market Value (US$ Million) by Product, 2023 to 2033
Figure 82: South Asia Market Value (US$ Million) by Application, 2023 to 2033
Figure 83: South Asia Market Value (US$ Million) by End-User , 2023 to 2033
Figure 84: South Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 85: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 88: South Asia Market Value (US$ Million) Analysis by Product, 2018 to 2033
Figure 89: South Asia Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 91: South Asia Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 92: South Asia Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 94: South Asia Market Value (US$ Million) Analysis by End-User , 2018 to 2033
Figure 95: South Asia Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033
Figure 96: South Asia Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033
Figure 97: South Asia Market Attractiveness by Product, 2023 to 2033
Figure 98: South Asia Market Attractiveness by Application, 2023 to 2033
Figure 99: South Asia Market Attractiveness by End-User , 2023 to 2033
Figure 100: South Asia Market Attractiveness by Country, 2023 to 2033
Figure 101: East Asia Market Value (US$ Million) by Product, 2023 to 2033
Figure 102: East Asia Market Value (US$ Million) by Application, 2023 to 2033
Figure 103: East Asia Market Value (US$ Million) by End-User , 2023 to 2033
Figure 104: East Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 105: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 108: East Asia Market Value (US$ Million) Analysis by Product, 2018 to 2033
Figure 109: East Asia Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 111: East Asia Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 112: East Asia Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 114: East Asia Market Value (US$ Million) Analysis by End-User , 2018 to 2033
Figure 115: East Asia Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033
Figure 116: East Asia Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033
Figure 117: East Asia Market Attractiveness by Product, 2023 to 2033
Figure 118: East Asia Market Attractiveness by Application, 2023 to 2033
Figure 119: East Asia Market Attractiveness by End-User , 2023 to 2033
Figure 120: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 121: Oceania Market Value (US$ Million) by Product, 2023 to 2033
Figure 122: Oceania Market Value (US$ Million) by Application, 2023 to 2033
Figure 123: Oceania Market Value (US$ Million) by End-User , 2023 to 2033
Figure 124: Oceania Market Value (US$ Million) by Country, 2023 to 2033
Figure 125: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 128: Oceania Market Value (US$ Million) Analysis by Product, 2018 to 2033
Figure 129: Oceania Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 131: Oceania Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 132: Oceania Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 134: Oceania Market Value (US$ Million) Analysis by End-User , 2018 to 2033
Figure 135: Oceania Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033
Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033
Figure 137: Oceania Market Attractiveness by Product, 2023 to 2033
Figure 138: Oceania Market Attractiveness by Application, 2023 to 2033
Figure 139: Oceania Market Attractiveness by End-User , 2023 to 2033
Figure 140: Oceania Market Attractiveness by Country, 2023 to 2033
Figure 141: MEA Market Value (US$ Million) by Product, 2023 to 2033
Figure 142: MEA Market Value (US$ Million) by Application, 2023 to 2033
Figure 143: MEA Market Value (US$ Million) by End-User , 2023 to 2033
Figure 144: MEA Market Value (US$ Million) by Country, 2023 to 2033
Figure 145: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 148: MEA Market Value (US$ Million) Analysis by Product, 2018 to 2033
Figure 149: MEA Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 150: MEA Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 151: MEA Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 152: MEA Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 153: MEA Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 154: MEA Market Value (US$ Million) Analysis by End-User , 2018 to 2033
Figure 155: MEA Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033
Figure 156: MEA Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033
Figure 157: MEA Market Attractiveness by Product, 2023 to 2033
Figure 158: MEA Market Attractiveness by Application, 2023 to 2033
Figure 159: MEA Market Attractiveness by End-User , 2023 to 2033
Figure 160: MEA Market Attractiveness by Country, 2023 to 2033
